Nieuwe ontwikkelingen bij lymfoproliferatieve aandoeningen

A. Janssens; G. Verhoef

doi:10.2143/TVG.73.09.2002333

Nieuwe ontwikkelingen bij lymfoproliferatieve aandoeningen

Translated title of the contribution: New developments in lymphoproliferative disorders

A. Janssens, G. Verhoef^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

The lymphoproliferative disorders compromise a large group of entities that were classified by the World Health Organization according to clinical characteristics, histology, immunophenotyping and cytogenetic/molecular abnormalities. Treatment and long-term outcome are different for each type and are mainly driven by the subtype of lymphoma. In this overview, the characteristics of the five most common subtypes are described. Clinical characteristics, staging procedures, treatment and new trends are discussed.

Original language	Dutch
Pages (from-to)	563-569
Number of pages	7
Journal	Tijdschrift voor Geneeskunde
Volume	73
Issue number	9
DOIs	https://doi.org/10.2143/TVG.73.09.2002333
Publication status	Published - 1 May 2017

Access to Document

10.2143/TVG.73.09.2002333

Link to publication in Scopus

Cite this

Janssens, A., & Verhoef, G. (2017). Nieuwe ontwikkelingen bij lymfoproliferatieve aandoeningen. Tijdschrift voor Geneeskunde, 73(9), 563-569. https://doi.org/10.2143/TVG.73.09.2002333

@article{7047f73778434274959cdae2cb07a009,

title = "Nieuwe ontwikkelingen bij lymfoproliferatieve aandoeningen",

abstract = "The lymphoproliferative disorders compromise a large group of entities that were classified by the World Health Organization according to clinical characteristics, histology, immunophenotyping and cytogenetic/molecular abnormalities. Treatment and long-term outcome are different for each type and are mainly driven by the subtype of lymphoma. In this overview, the characteristics of the five most common subtypes are described. Clinical characteristics, staging procedures, treatment and new trends are discussed.",

author = "A. Janssens and G. Verhoef",

year = "2017",

month = "5",

day = "1",

doi = "10.2143/TVG.73.09.2002333",

language = "Dutch",

volume = "73",

pages = "563--569",

journal = "Tijdschrift voor Sociale Geneeskunde",

issn = "0040-7607",

publisher = "Van Gorcum",

number = "9",

}

TY - JOUR

T1 - Nieuwe ontwikkelingen bij lymfoproliferatieve aandoeningen

AU - Janssens, A.

AU - Verhoef, G.

PY - 2017/5/1

Y1 - 2017/5/1

N2 - The lymphoproliferative disorders compromise a large group of entities that were classified by the World Health Organization according to clinical characteristics, histology, immunophenotyping and cytogenetic/molecular abnormalities. Treatment and long-term outcome are different for each type and are mainly driven by the subtype of lymphoma. In this overview, the characteristics of the five most common subtypes are described. Clinical characteristics, staging procedures, treatment and new trends are discussed.

AB - The lymphoproliferative disorders compromise a large group of entities that were classified by the World Health Organization according to clinical characteristics, histology, immunophenotyping and cytogenetic/molecular abnormalities. Treatment and long-term outcome are different for each type and are mainly driven by the subtype of lymphoma. In this overview, the characteristics of the five most common subtypes are described. Clinical characteristics, staging procedures, treatment and new trends are discussed.

UR - http://www.scopus.com/inward/record.url?scp=85020084005&partnerID=8YFLogxK

U2 - 10.2143/TVG.73.09.2002333

DO - 10.2143/TVG.73.09.2002333

M3 - Article

AN - SCOPUS:85020084005

VL - 73

SP - 563

EP - 569

JO - Tijdschrift voor Sociale Geneeskunde

JF - Tijdschrift voor Sociale Geneeskunde

SN - 0040-7607

IS - 9

ER -